February 2014 Recap of Drug Updates

 

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of February. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME	UPDATES
(Click on drug name to go to MPR monograph.)	D	IND	ITX	CI	W/P	ADR	HS	MFR
AMERGE (Naratriptan)		X	X	X	X
BIDIL (Isosorbide dinitrate, hydralazine)								X
CIPRO XR (Ciprofloxacin)			X		X	X	X
CORDRAN TAPE (Flurandrenolide)				X	X	X	X
ENTEREG (Alvimopan)		X			X
LEVAQUIN (Levofloxacin)	X	X			X	X	X
METHYLIN CHEWABLE (Methylphenidate)					X	X	X
NEXAVAR (Sorafenib)	X	X			X
NOVOLOG (Insulin aspart)							X
ONFI (Clobazam)					X
RITALIN LA (Methylphenidate)					X	X
SAPHRIS (Asenapine)								X
SIRTURO (Bedaquiline)		X
VYVANSE (Lisdexamfetamine)	X		X		X	X
XIAFLEX (Collagenase clostridium histolyticum)		X

Review more drug monograph updates